Tag: Dan Barber
Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data For Anaphylm™ (Epinephrine) Sublingual...
"Anaphylm allows patients to have medication with them where they need it, when they need it and is convenient enough to carry in their wallets or pockets.”
Anaphylm™, Aquestive’s Needleless Sublingual Epinephrine, Takes Another Step Forward
Company reports positive topline results from phase 2 study.
Aquestive Receives Positive FDA Response to Epinephrine Sublingual Film Phase 2...
Response confirms approach and supports the characterization of their novel drug platform.
Aquestive’s Sublingual Emergency Epinephrine Compares Favorably to EpiPen® in EPIPHAST II...
The company announced topline results from their EPIPHAST II study.
Aquestive Reports Positive Results from Sublingual Epinephrine Clinical Trial
Phase 2 study continues to show AQST-109 is safe and well tolerated.
Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine
Company updates the public on status of their candidate drug administered under the tongue.
